[#item_full_content] Rescheduling took medical cannabis companies out from under Section 280E, which barred them from deducting ordinary business expenses. Now, the R&D credit has opened up, requiring thorough… 
Read More
[#item_full_content] Rescheduling took medical cannabis companies out from under Section 280E, which barred them from deducting ordinary business expenses. Now, the R&D credit has opened up, requiring thorough… Read More